Abstract
ADP plays a crucial role in haemostasis and thrombosis and its receptors are potential target for antithrombotic drugs.The knowledge of the ADP-receptors has been amplified by recent discoveries. This review highlights the ADP-receptors models and their antagonists described in the recent literature, mainly the thienopyridine derivatives.
Keywords: adenosine diphosphate, adp receptors, receptors, antithrombotics, platelets
Mini-Reviews in Medicinal Chemistry
Title: Platelet ADP Receptors and their Antagonists
Volume: 3 Issue: 2
Author(s): Patricia Benoit and Jean-Michel Dogné
Affiliation:
Keywords: adenosine diphosphate, adp receptors, receptors, antithrombotics, platelets
Abstract: ADP plays a crucial role in haemostasis and thrombosis and its receptors are potential target for antithrombotic drugs.The knowledge of the ADP-receptors has been amplified by recent discoveries. This review highlights the ADP-receptors models and their antagonists described in the recent literature, mainly the thienopyridine derivatives.
Export Options
About this article
Cite this article as:
Benoit Patricia and Dogné Jean-Michel, Platelet ADP Receptors and their Antagonists, Mini-Reviews in Medicinal Chemistry 2003; 3 (2) . https://dx.doi.org/10.2174/1389557033405412
DOI https://dx.doi.org/10.2174/1389557033405412 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Thromboprophylaxis in Medical Patients: An Update
Vascular Disease Prevention (Discontinued) Vitamin E-Related Inhibition of Monocyte 5-Lipoxygenase and Cardiovascular Outcome in Maintenance Hemodialysis Patients
Recent Patents on Inflammation & Allergy Drug Discovery Brachial-Ankle Pulse Wave Velocity as a Novel Measure of Arterial Stiffness: Present Evidences and Perspectives
Current Hypertension Reviews Late Onset Alzheimer’s Disease: Novel Clinical Prospects for the Future
Current Neurovascular Research Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research Hypertension, Cognitive Impairment and Dementia: An Epidemiological Perspective
Current Hypertension Reviews Probing Cerebrovascular Alterations in Alzheimers Disease Using MRI: From Transgenic Models to Patients
Current Medical Imaging ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries
Current Drug Targets Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Patented Biomarkers of Peripheral Blood for the Early Detection of Cancer
Recent Patents on Biomarkers The Proteasome as a Therapeutic Target for Lung Fibrosis
Current Enzyme Inhibition Ion Channel Architecture of the Renal Microcirculation
Current Hypertension Reviews Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis
Current Medicinal Chemistry Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug
Current Clinical Pharmacology Cardiovascular Risk Factors, Metabolic Complications, & the Natural Course of CKD in Children
Current Hypertension Reviews Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
Current Cancer Therapy Reviews Effects of Thiazolidinediones Beyond Glycaemic Control
Current Pharmaceutical Design